EUVIMEDScopri EUVIMED
Crossref

The diagnostic yield of non-invasive testing features in cardiac amyloidosis

Domagoj Kustić iD, Josipa Vukšić, Dražen Huić

Nuclear Medicine Review · 2025

DOI: 10.5603/nmr.103627 ↗

At a glance

Journal article in Nuclear Medicine Review, 2025. Written by Domagoj Kustić and 2 co-authors. Institution: Clinical Department of Nuclear Medicine, Clinical Hospital Center Rijeka, Rijeka, Croatia. domagoj.kustic.d@gmail.com. Major MEDLINE topics: Amyloidosis.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Cardiac amyloidosis (CA) is a progressive disease in which amyloid fibrils infiltrate the heart muscle. This study aimed to identify features from cardiac biomarkers, electrocardiography (ECG), and echocardiography that may distinguish between transthyretin amyloidosis (ATTR) scintigraphy-positive and negative patients. Material and methods: Seventy-eight consecutive patients, median age 69 years (range 34–81), with suspected CA, negative serum free light chains, and negative serum and urine protein electrophoresis with immunofixation, referred to cardiac scintigraphy between 2021 and 2024, were retrospectively enrolled. Cardiac uptake was assessed by Perugini grades. Troponin T, N-terminal pro-B-type natriuretic peptide (NT-proBNP), and various ECG and echocardiographic features were compared between ATTR scintigraphy-positive and negative participants using the t-test, Mann–Whitney U-test, and χ2-test as appropriate. Multivariable stepwise logistic regression created the prediction model for ATTR-positive scintigraphy. The significance level was 0.05.

Results

Scintigraphy was ATTR-positive in 24 participants (30.77%). The variables significantly connected with ATTR-positive testing were atrial fibrillation (p = 0.010), first- or second-degree atrioventricular block (p = 0.041), left ventricle (LV) end-diastolic dimension (p = 0.018), LV global longitudinal strain (GLS) (p = 0.040), a restrictive transmitral inflow pattern (p = 0.025), LV posterior wall thickness (p < 0.001), interventricular septum (IVS) thickness (p < 0.001), QRS voltages (p < 0.001), the pseudo- infarct pattern (p < 0.001), and relative apical sparing of the GLS ratio (p < 0.001). The latter four were incorporated into the prediction model for ATTR-positive scintigraphy.

Conclusions

ECG and echocardiography remain the essential diagnostic procedures that raise the suspicion of CA and trigger further diagnostics. Low QRS voltages, the pseudo-infarct pattern, IVS thickness, and relative apical sparing of the GLS ratio are sensitive predictors of ATTR-positive scintigraphy findings.

Subjects

MeSH terms (MEDLINE)

AmyloidosisHumansAgedMiddle AgedMaleFemaleAged, 80 and overAdultRetrospective StudiesEchocardiographyElectrocardiographyAmyloid Neuropathies, Familial

Author keywords

amyloidosisechocardiographyelectrocardiographyrestrictive cardiomyopathyscintigraphysingle-photon emission computerized tomographytransthyretin

Authors and institutions

  • Clinical Department of Nuclear Medicine, Clinical Hospital Center Rijeka, Rijeka, Croatia. domagoj.kustic.d@gmail.com.
  • Faculty of Medicine Rijeka, Rijeka, Croatia. domagoj.kustic.d@gmail.com.
  • Department of Nuclear Medicine, General Hospital of Šibenik, Šibenik, Croatia.
  • Clinical Department of Nuclear Medicine and Radiation Protection, Clinical Hospital Centre Zagreb, Zagreb, Croatia.
  • School of Medicine Zagreb, Zagreb, Croatia.

ORCID profiles: Domagoj Kustić

Cite

APA

Kustić, D., Vukšić, J., & Huić, D. (2025). The diagnostic yield of non-invasive testing features in cardiac amyloidosis. Nuclear Medicine Review. https://doi.org/10.5603/nmr.103627

Vancouver

Kustić D, Vukšić J, Huić D. The diagnostic yield of non-invasive testing features in cardiac amyloidosis. Nuclear Medicine Review. 2025. doi:10.5603/nmr.103627

BibTeX
@article{Kusti2025,
  author = {Kustić, Domagoj and Vukšić, Josipa and Huić, Dražen},
  title = {The diagnostic yield of non-invasive testing features in cardiac amyloidosis},
  journal = {Nuclear Medicine Review},
  year = {2025},
  doi = {10.5603/nmr.103627}
}
Start for free →